Skip to main content
. 2020 Feb 21;10:181. doi: 10.3389/fonc.2020.00181

Figure 7.

Figure 7

KM survival curve and log-rank test for patients with Cbl-b high or low expression in different pathological types of NSCLC and LUAD at Stage I, Stage II, Stage III. Online Kaplan Meier plotter Database was used to analysis. (A) KM survival curve of Cbl-b in non-small cell lung cancer (NSCLC), lung adenocarcinoma (LUAD), lung squamous carcinoma (LUSC). (B) KM survival curve of Cbl-b in different pathological stage in LUAD.